PTC Therapeutics(DE:BH3)
€53.78-2.86 (-5.05%)
DE:BH3
PTC Therapeutics earnings date
€53.78
At close:-2.86 (-5.05%)
PTC Therapeutics (BH3) Q2 2026 Earnings Report
0 Followers
DE:BH3 Q2 2026 EPS Results
- Actual EPS
- EUR 0.82
- Consensus EPS
- EUR 0.21
- Beat/Miss
- Beat by +EUR 0.61
- One Year Ago EPS
- -EUR 0.74
DE:BH3 Q2 2026 Revenue Results
- Actual Revenue
- EUR 322.34M
- Expected Revenue
- EUR 267.01M
- Beat/Miss
- Beat by +EUR 55.33M
- YoY Revenue Growth
- +101.55%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/30/2026
- Time
- After Close
- Conference Call
- Thursday, July 30, 2026
DE:BH3 Upcoming Earnings
PTC Therapeutics's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:BH3 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BH3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2026 (Q4) | 0.31- | -1.49 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.13-0.55 | 0.18 | -410.00% (-0.73) | |
| Jul 30, 2026 | 2026 (Q2) | 0.210.82 | -0.74 | 210.84% (+1.56) | |
| May 07, 2026 | 2026 (Q1) | -0.42-0.03 | 8.98 | -100.30% (-9.00) | |
| Feb 19, 2026 | 2025 (Q4) | 0.09-1.49 | -0.76 | -96.47% (-0.73) | |
| Nov 04, 2025 | 2025 (Q3) | -1.010.18 | -1.24 | 114.39% (+1.42) | |
| Aug 07, 2025 | 2025 (Q2) | -0.91-0.74 | -1.15 | 35.66% (+0.41) | |
| May 06, 2025 | 2025 (Q1) | -0.908.98 | -1.07 | 936.67% (+10.05) | |
| Feb 27, 2025 | 2024 (Q4) | -0.48-0.76 | -1.84 | 58.74% (+1.08) | |
| Nov 07, 2024 | 2024 (Q3) | -1.36-1.24 | -1.57 | 21.02% (+0.33) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

